Diseases
Optimizing the MDS-UPDRS for Early-Stage Parkinson's Disease: New Breakthrough in Neurodegenerative Research
A team of researchers has made significant strides in developing a more effective assessment tool for Parkinson's disease, specifically targeting early-stage patients. By applying a cross-sectional Rasch model to the Parkinson's Progression Markers Initiative (PPMI) untreated PD cohort data, the team identified a sub-score of 15